1. DOP33 Single-cell analysis identifies pathological fibroblasts as a new therapeutic target to prevent intestinal fibrosis in Crohn's disease. (30th January 2023) Authors: Ke, B J; Abdurahiman, S; Biscu, F; Verstockt, S; Verstockt, B; de Hertogh, G; Vermeire, S; Matteoli, G Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P495 Vedolizumab trough concentrations and histological remission in Ulcerative Colitis: Results from the LOVE-UC study. (30th January 2023) Authors: Hanzel, J; Baert, F; Löwenberg, M; Ferrante, M; Bossuyt, P; Hoentjen, F; Franchimont, D; Palatka, K; Peeters, H; Mookhoek, A; de Hertogh, G; Clasquin, E; Vermeire, S; D'Haens, G Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i625 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗